Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

276.42USD
19 Jan 2018
Change (% chg)

$1.12 (+0.41%)
Prev Close
$275.30
Open
$276.11
Day's High
$278.89
Day's Low
$275.70
Volume
53,247
Avg. Vol
69,999
52-wk High
$278.89
52-wk Low
$162.99

Latest Key Developments (Source: Significant Developments)

Teleflex Signs New Agreement With Healthtrust For Respiratory Heaters & Accessories
Tuesday, 12 Dec 2017 06:45am EST 

Dec 12 (Reuters) - Teleflex Inc ::TELEFLEX SIGNS NEW AGREEMENT WITH HEALTHTRUST FOR RESPIRATORY HEATERS & ACCESSORIES.TELEFLEX - AGREEMENT COVERS CO'S FULL LINE OF ACTIVE HUMIDIFICATION, NON INVASIVE VENTILATION, HIGH FLOW NASAL CANNULA THERAPY PRODUCTS.  Full Article

Teleflex announces pricing of $500 mln senior notes offering
Thursday, 16 Nov 2017 05:00pm EST 

Nov 16 (Reuters) - Teleflex Inc :Teleflex Incorporated announces pricing of $500 million senior notes offering.Teleflex Inc - ‍Priced offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 at an issue price of 100.000%​.  Full Article

Teleflex announces public offering of $500 mln of senior notes
Thursday, 16 Nov 2017 08:00am EST 

Nov 16 (Reuters) - Teleflex Inc :Teleflex Incorporated announces public offering of $500 million of senior notes.Teleflex Inc - ‍intends to use net proceeds from offering to repay approximately $491.2 million of borrowings under its revolving credit facility​.Teleflex Inc - ‍registered public offering of $500.0 million aggregate principal amount of senior notes due 2027​.  Full Article

Teleflex reports Q3 adjusted profit of $2.12/shr
Thursday, 2 Nov 2017 06:30am EDT 

Nov 2 (Reuters) - Teleflex Inc :Teleflex reports third quarter 2017 results.Q3 adjusted earnings per share $2.12 from continuing operations.Q3 GAAP earnings per share $1.70 from continuing operations.Q3 revenue $534.7 million versus I/B/E/S view $523.1 million.Q3 earnings per share view $2.00 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $8.30 to $8.40 from continuing operations.Sees FY 2017 GAAP earnings per share $5.61 to $5.66 from continuing operations.‍lowered 2017 guidance for GAAP diluted EPS from a range of $5.91 to $5.98 to a range of $5.61 to $5.66​.Raised 2017 guidance for adjusted diluted EPS from a range of $8.20 to $8.35 to a range of $8.30 to $8.40.Teleflex Inc- co raised its full year 2017 GAAP revenue growth guidance range from 11.5 percent to 13.0 percent to a range of 15.0 percent to 15.5 percent over the prior year.FY 2017 earnings per share view $8.29, revenue view $2.11 billion -- Thomson Reuters I/B/E/S.Teleflex Inc - ‍raised 2017 guidance range for constant currency revenue growth to a range of 14.25 percent to 14.75 percent​.  Full Article

Teleflex awarded group purchasing contract with Vizient for central venous catheters
Wednesday, 23 Aug 2017 06:45am EDT 

Aug 23 (Reuters) - Teleflex Inc :Teleflex awarded group purchasing contract with Vizient Inc for non-tunneled central venous catheters.Teleflex Inc - ‍Announced a new three year product category contract with Vizient Inc​.Teleflex Inc - ‍New agreement for non-tunneled central venous catheters, became effective August 1, 2017​.  Full Article

Arrow Seldinger Arterial Catheterization Device receives FDA market clearance - Teleflex Inc
Monday, 24 Jul 2017 06:45am EDT 

July 24 (Reuters) - Teleflex Inc :Teleflex Inc says that its Arrow Seldinger Arterial Catheterization Device received market clearance from U.S. Food And Drug Administration.Teleflex Inc - expects to launch Arrow Seldinger Arterial Catheterization Device in United States this year.  Full Article

Teleflex commences phase I clinical study of RePlas freeze-dried plasma
Monday, 15 May 2017 06:30am EDT 

May 15 (Reuters) - Teleflex Inc :Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma.Teleflex inc- RePlas, a lyophilized fresh frozen plasma product, being developed in collaboration with U.S. Army medical materiel development activity.  Full Article

Teleflex Q1 adjusted earnings per share $1.80 from continuing operations
Thursday, 4 May 2017 06:30am EDT 

May 4 (Reuters) - Teleflex Inc ::Teleflex reports first quarter 2017 results.Q1 adjusted earnings per share $1.80 from continuing operations.Q1 gaap earnings per share $0.87 from continuing operations.Q1 revenue $487.9 million versus I/B/E/S view $472.7 million.Q1 earnings per share view $1.69 -- Thomson Reuters I/B/E/S.Sees fy 2017 gaap earnings per share $5.59 to $5.66 from continuing operations.Teleflex - reaffirms 2017 guidance range for gaap revenue growth of 10.0 pct to 11.5 pct and constant currency revenue growth of 12.5 pct to 14.0 pct.Teleflex - raises 2017 guidance for adjusted diluted eps from a range of $8.00 to $8.15 to a range of $8.05 to $8.23.Fy2017 earnings per share view $8.10, revenue view $2.07 billion -- Thomson Reuters I/B/E/S.  Full Article

Teleflex receives FDA 510(k) clearance for Arrow AC3 Optimustm Intra-Aortic Balloon Pump
Tuesday, 2 May 2017 06:45am EDT 

May 2 (Reuters) - Teleflex Inc :Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp).Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp).Teleflex inc- ac3 optimus iabp will be launched at two scientific meetings in may.  Full Article

Pyng receives final order for acquisition by Teleflex
Wednesday, 29 Mar 2017 04:36pm EDT 

Pyng Medical Corp : Pyng receives final order for acquisition by Teleflex .Pyng Medical - supreme court approved plan of arrangement whereby all of issued, outstanding shares of co to be acquired by Teleflex Medical Canada Inc.  Full Article

BRIEF-Teleflex Signs New Agreement With Healthtrust For Respiratory Heaters & Accessories

* TELEFLEX SIGNS NEW AGREEMENT WITH HEALTHTRUST FOR RESPIRATORY HEATERS & ACCESSORIES